Novo Nordisk's pricing approaches from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of selling price gouging, pointing out the stark contrast concerning U.S. rates and people in Europe and copyright.Scientific tests of Rybelsus and copyright have revealed that both of those drugs are efficien